Rudberg S, Dahlquist G
Department of Woman and Child Health Pediatric Unit, Karolinska Institute, St. Göran's Children's Hospital, Stockholm, Sweden.
Diabetes Care. 1996 Apr;19(4):369-71. doi: 10.2337/diacare.19.4.369.
To evaluate the significance of microalbuminuria in adolescents with IDDM and to study the relative importance of blood pressure (BP), metabolic control, and albumin excretion rate (AER) on progression of microalbuminuria.
A cohort of 155/156 children and adolescents followed from onset up to 18.3 years of IDDM participated. In a previous follow-up in July 1991 (up to 15 years of duration), 17 patients had developed persistent microalbuminuria (> or = 20 micrograms/min). In these adolescents, we analyzed whether microalbuminuria had progressed (in mean > or = 5% per year), had remained unchanged, or had normalized (< 20 micrograms/min) after another 3 years. The predictive values of mean HbA1c, diastolic blood pressure (dBP), systolic blood pressure (sBP), overnight AER, sex, age, and duration of diabetes for the progression of microalbuminuria were determined using multiple regression modeling.
Seven of 17 patients with microalbuminuria in July 1991 had normalized, 6 of 17 patients had progressed, and 4 of 17 patients had remained unchanged after 3 years. Progressors had higher mean HbA1c during the first 5 years of IDDM and higher mean sBP in 1991 than nonprogressors. Patients with normalized microalbuminuria all had AER < 30 micrograms/min in 1991, were younger at onset of microalbuminuria, had lower mean HbA1c, and had lower dBP before normalized AER than nonregressors at the same duration of microalbuminuria. In multivariate analysis, independent significant predictors for progression were first 5-year mean HbA1c, mean AER, and mean sBP in 1991 (R2 = 0.76, P = 0.001).
Progression of microalbuminuria in adolescents with IDDM is predicted by early sustained hyperglycemia, later elevated sBP, and increased AER per se. Microalbuminuria is frequently normalized in adolescents, and this is associated with better prevailing metabolic control, younger age, and lower dBP.
评估微量白蛋白尿在青少年胰岛素依赖型糖尿病(IDDM)中的意义,并研究血压(BP)、代谢控制及白蛋白排泄率(AER)对微量白蛋白尿进展的相对重要性。
155/156名儿童及青少年参与研究,自IDDM发病起随访至18.3岁。在1991年7月的一次随访(长达15年)中,17例患者出现持续性微量白蛋白尿(≥20微克/分钟)。在这些青少年中,我们分析了经过另外3年后微量白蛋白尿是否进展(平均每年≥5%)、是否保持不变或已恢复正常(<20微克/分钟)。使用多元回归模型确定平均糖化血红蛋白(HbA1c)、舒张压(dBP)、收缩压(sBP)、夜间AER、性别、年龄及糖尿病病程对微量白蛋白尿进展的预测价值。
1991年7月有微量白蛋白尿的17例患者中,7例恢复正常,6例进展,4例3年后保持不变。进展者在IDDM发病的前5年平均HbA1c较高,1991年平均sBP高于未进展者。微量白蛋白尿恢复正常的患者在1991年AER均<30微克/分钟,微量白蛋白尿发病时年龄较小,平均HbA1c较低,且在AER恢复正常前舒张压低于相同微量白蛋白尿病程的未恢复者。多变量分析中,进展的独立显著预测因素为发病后前5年的平均HbA1c、平均AER及1991年的平均sBP(R2 = 0.76,P = 0.001)。
青少年IDDM患者微量白蛋白尿的进展可由早期持续高血糖、后期升高的sBP及AER本身升高预测。青少年微量白蛋白尿常恢复正常,这与更好的当前代谢控制、较年轻的年龄及较低的dBP相关。